FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1765975574> ?p ?o ?g. }

• W1765975574 endingPage "158" @default.
• W1765975574 startingPage "155" @default.
• W1765975574 abstract "AIM: N -acetyltransferase 2 (NAT2) is an important enzyme catalyzing N -acetylation of sulfasalazine (SASP). The aim of the present study was to investigate associations of the genotypes of NAT2 with inflammatory bowel disease (IBD), and with adverse effects of SASP, which is used as the first-line treatment of IBD. PATIENTS AND METHODS: The wildtype allele ( NAT2*4 ) and three variant alleles ( NAT2*5B, NAT2*6A and NAT*7B ) of the NAT2 gene were determined in 101 patients with IBD (84 patients with ulcerative colitis and 17 patients with Crohn’s disease) and 109 healthy controls by the polymerase chain reaction-restriction fragment length polymorphism method. Sixty-eight patients with IBD treated with SASP were followed, and their adverse reactions were recorded. RESULTS: Eleven patients (16%) experienced adverse effects from SASP, including nine cases of sulfapyridine (SP) dose-related adverse effects and two cases of hypersensitivity (skin rash). Patients with the slow acetylator genotypes without the NAT2*4 allele experienced adverse effects more frequently (36%) than those with the fast acetylator genotypes with at least one NAT2*4 allele (11%), but the results were not significantly different (OR of 0.26, 95% CI 0.065 to 1.004; P=0.051). However, those with the slow acetylator genotypes experienced more SP dose-related adverse effects than those with the fast acetylator genotypes (36% versus 8%, OR of 0.17, 95% CI 0.039 to 0.749; P=0.019). CONCLUSIONS: The NAT2 gene polymorphism was not associated with susceptibility to IBD in Chinese populations, but the NAT2 slow acetylator genotypes were significantly associated with SP dose-related adverse effects of SASP in the treatment of IBD." @default.
• W1765975574 created "2016-06-24" @default.
• W1765975574 creator A5012718640 @default.
• W1765975574 creator A5020075019 @default.
• W1765975574 creator A5023512298 @default.
• W1765975574 creator A5037829735 @default.
• W1765975574 creator A5041537110 @default.
• W1765975574 creator A5047379544 @default.
• W1765975574 creator A5070699088 @default.
• W1765975574 date "2007-01-01" @default.
• W1765975574 modified "2023-10-12" @default.
• W1765975574 title "<i>N</i>-acetyltransferase 2 Slow Acetylator Genotype Associated with Adverse Effects of Sulfasalazine in the Treatment of Inflammatory Bowel Disease" @default.
• W1765975574 cites W1587924678 @default.
• W1765975574 cites W1804057407 @default.
• W1765975574 cites W1984399473 @default.
• W1765975574 cites W1988855705 @default.
• W1765975574 cites W1989737284 @default.
• W1765975574 cites W2018467743 @default.
• W1765975574 cites W2050856014 @default.
• W1765975574 cites W2066076563 @default.
• W1765975574 cites W2067939984 @default.
• W1765975574 cites W2081817010 @default.
• W1765975574 cites W2092128596 @default.
• W1765975574 cites W2145700331 @default.
• W1765975574 cites W2150362538 @default.
• W1765975574 cites W2152948004 @default.
• W1765975574 cites W2153972688 @default.
• W1765975574 cites W2188554637 @default.
• W1765975574 cites W235627259 @default.
• W1765975574 cites W2385897710 @default.
• W1765975574 cites W2407146906 @default.
• W1765975574 cites W2914927255 @default.
• W1765975574 cites W87254141 @default.
• W1765975574 doi "https://doi.org/10.1155/2007/976804" @default.
• W1765975574 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2657682" @default.
• W1765975574 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17377643" @default.
• W1765975574 hasPublicationYear "2007" @default.
• W1765975574 type Work @default.
• W1765975574 sameAs 1765975574 @default.
• W1765975574 citedByCount "48" @default.
• W1765975574 countsByYear W17659755742012 @default.
• W1765975574 countsByYear W17659755742013 @default.
• W1765975574 countsByYear W17659755742014 @default.
• W1765975574 countsByYear W17659755742015 @default.
• W1765975574 countsByYear W17659755742016 @default.
• W1765975574 countsByYear W17659755742017 @default.
• W1765975574 countsByYear W17659755742018 @default.
• W1765975574 countsByYear W17659755742020 @default.
• W1765975574 countsByYear W17659755742021 @default.
• W1765975574 countsByYear W17659755742022 @default.
• W1765975574 countsByYear W17659755742023 @default.
• W1765975574 crossrefType "journal-article" @default.
• W1765975574 hasAuthorship W1765975574A5012718640 @default.
• W1765975574 hasAuthorship W1765975574A5020075019 @default.
• W1765975574 hasAuthorship W1765975574A5023512298 @default.
• W1765975574 hasAuthorship W1765975574A5037829735 @default.
• W1765975574 hasAuthorship W1765975574A5041537110 @default.
• W1765975574 hasAuthorship W1765975574A5047379544 @default.
• W1765975574 hasAuthorship W1765975574A5070699088 @default.
• W1765975574 hasBestOaLocation W17659755741 @default.
• W1765975574 hasConcept C104317684 @default.
• W1765975574 hasConcept C126322002 @default.
• W1765975574 hasConcept C135763542 @default.
• W1765975574 hasConcept C149737253 @default.
• W1765975574 hasConcept C178790620 @default.
• W1765975574 hasConcept C180754005 @default.
• W1765975574 hasConcept C185592680 @default.
• W1765975574 hasConcept C197934379 @default.
• W1765975574 hasConcept C2777031107 @default.
• W1765975574 hasConcept C2778260677 @default.
• W1765975574 hasConcept C2778328694 @default.
• W1765975574 hasConcept C2778570526 @default.
• W1765975574 hasConcept C2779134260 @default.
• W1765975574 hasConcept C2779383735 @default.
• W1765975574 hasConcept C2780479503 @default.
• W1765975574 hasConcept C54355233 @default.
• W1765975574 hasConcept C71924100 @default.
• W1765975574 hasConcept C86803240 @default.
• W1765975574 hasConcept C90924648 @default.
• W1765975574 hasConceptScore W1765975574C104317684 @default.
• W1765975574 hasConceptScore W1765975574C126322002 @default.
• W1765975574 hasConceptScore W1765975574C135763542 @default.
• W1765975574 hasConceptScore W1765975574C149737253 @default.
• W1765975574 hasConceptScore W1765975574C178790620 @default.
• W1765975574 hasConceptScore W1765975574C180754005 @default.
• W1765975574 hasConceptScore W1765975574C185592680 @default.
• W1765975574 hasConceptScore W1765975574C197934379 @default.
• W1765975574 hasConceptScore W1765975574C2777031107 @default.
• W1765975574 hasConceptScore W1765975574C2778260677 @default.
• W1765975574 hasConceptScore W1765975574C2778328694 @default.
• W1765975574 hasConceptScore W1765975574C2778570526 @default.
• W1765975574 hasConceptScore W1765975574C2779134260 @default.
• W1765975574 hasConceptScore W1765975574C2779383735 @default.
• W1765975574 hasConceptScore W1765975574C2780479503 @default.
• W1765975574 hasConceptScore W1765975574C54355233 @default.
• W1765975574 hasConceptScore W1765975574C71924100 @default.
• W1765975574 hasConceptScore W1765975574C86803240 @default.
• W1765975574 hasConceptScore W1765975574C90924648 @default.

• next